Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy
- PMID: 15635725
- DOI: 10.1002/psc.587
Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy
Abstract
The IgG-derived immunomodulating peptide tuftsin, Thr-Lys-Pro-Arg, is recognized by specific receptors on phagocytic cells, notably macrophages, and is capable of targeting proteins and peptides to these sites. Aiming to target 3'-azido-3'-deoxythymidine (AZT) to HIV-infected macrophages, a conjugate of AZT with tuftsin was synthesized. The AZT-tuftsin chimera possesses the characteristic capacities of its two components. Thus, like AZT, it inhibits reverse transcriptase activity and HIV-antigen expression, and similarly to tuftsin, it stimulates IL-1 release from mouse macrophages and augments the immunogenic function of the cells. Importantly, the conjugate is not cytotoxic to T-cells. The results suggest that the AZT-tuftsin conjugate might have potential use in AIDS therapy.
Copyright (c) 2004 European Peptide Society and John Wiley & Sons, Ltd.
Similar articles
-
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.J Med Chem. 2005 Nov 17;48(23):7153-65. doi: 10.1021/jm050257d. J Med Chem. 2005. PMID: 16279773
-
Synthesis and antiviral activity of amino acid carbamate derivatives of AZT.Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):87-100. doi: 10.1080/15257770008032998. Nucleosides Nucleotides Nucleic Acids. 2000. PMID: 10772704
-
Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.Int J Clin Pharmacol Ther. 1995 Feb;33(2):85-8. Int J Clin Pharmacol Ther. 1995. PMID: 7757316
-
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors.Environ Mol Mutagen. 2007 Apr-May;48(3-4):215-23. doi: 10.1002/em.20195. Environ Mol Mutagen. 2007. PMID: 16395695 Review.
-
[Tuftsin].Allerg Immunol (Leipz). 1984;30(3):127-38. Allerg Immunol (Leipz). 1984. PMID: 6209973 Review. German.
Cited by
-
Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for Mycobacterium tuberculosis Infection-A Review.Pharmaceuticals (Basel). 2023 Oct 9;16(10):1428. doi: 10.3390/ph16101428. Pharmaceuticals (Basel). 2023. PMID: 37895899 Free PMC article. Review.
-
Vaccines, adjuvants and autoimmunity.Pharmacol Res. 2015 Oct;100:190-209. doi: 10.1016/j.phrs.2015.08.003. Epub 2015 Aug 12. Pharmacol Res. 2015. PMID: 26275795 Free PMC article. Review.
-
Targeting strategies for delivery of anti-HIV drugs.J Control Release. 2014 Oct 28;192:271-83. doi: 10.1016/j.jconrel.2014.08.003. Epub 2014 Aug 10. J Control Release. 2014. PMID: 25119469 Free PMC article. Review.
-
Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy.J Drug Deliv Sci Technol. 2009;19(1):3-14. doi: 10.1016/s1773-2247(09)50001-9. J Drug Deliv Sci Technol. 2009. PMID: 20717488 Free PMC article.
-
Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages.Bioconjug Chem. 2008 Jan;19(1):28-38. doi: 10.1021/bc070066k. Epub 2007 Dec 20. Bioconjug Chem. 2008. PMID: 18092743 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical